Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Advanced Hematologic Malignancies: Unexpected Renal Toxicity

✍ Scribed by K. van Besien; J. Kline; L. Godley; R.A. Larson; O. Odenike; E.S. Rich; W. Stock; A. Wickrema; K. Swanson; S. Horowitz; P. Del Cerro; L. Schroeder; L. Pape; S. Allen; A.S. Artz

• Book ID: 116280825
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 46 KB
• Volume: 15
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2008.12.324